Health and Fitness Health and Fitness
Mon, October 10, 2011
[ Mon, Oct 10th 2011 ] - Market Wire
St. Jude Medical Advances Its Remote Patient Monitoring System with Mobile Notifications
[ Mon, Oct 10th 2011 ] - Market Wire
St. Jude Medical migliora il proprio sistema di m .. zienti aggiungendovi un sistema di notifica mobil
[ Mon, Oct 10th 2011 ] - Market Wire
Equity Research on Humana Inc. and WellPoint Inc. - Obamacare Helping Several Health Insurers
[ Mon, Oct 10th 2011 ] - Market Wire
Natus Medical Announces Preliminary 2011 Third Quarter Revenue Results
[ Mon, Oct 10th 2011 ] - Market Wire
Prostate Cancer Joins Growing List of Cancers Tha .. Cellceutix Corporation's Potent Anti-Cancer Drug
[ Mon, Oct 10th 2011 ] - Market Wire
United Therapeutics Subsidiary Enters Into Contra .. f Health for Award of up to $45 Million to Suppor
[ Mon, Oct 10th 2011 ] - Market Wire
Medtronic Announces Results from TTOP-AF Trial De .. of Its Phased RF Ablation System in Treating Per
[ Mon, Oct 10th 2011 ] - Market Wire
Inovio Pharmaceuticals and VGX International to A .. C and Hepatitis B Synthetic Vaccines into Clinica
[ Mon, Oct 10th 2011 ] - Market Wire
PAREXEL and National University of Singapore Esta .. Meet Increasing Demand in Asia for Clinical Rese
Sun, October 9, 2011
[ Sun, Oct 09th 2011 ] - Market Wire
Watson Provides Update on District Court Order Concerning Generic Version of LOVENOX®
[ Sun, Oct 09th 2011 ] - Market Wire
Mylan Comments on Death of Company Co-Founder and Former Chairman and CEO Milan "Mike" Puskar
Sat, October 8, 2011
[ Sat, Oct 08th 2011 ] - Market Wire
FDA Approves Mercka?s JUVISYNCa" (sitagliptin and .. ;;;;;;; a Once-Daily Therap
[ Sat, Oct 08th 2011 ] - Market Wire
FDA Approves Mercka?s JUVISYNCa" (sitagliptin and .. ;;; a Once-Daily Therapy for Patients w
[ Sat, Oct 08th 2011 ] - Market Wire
FDA Approves Mercka?s JUVISYNCa" (sitagliptin and .. 9;; a Once-Daily Therapy for Patients with
[ Sat, Oct 08th 2011 ] - Market Wire
FDA Approves Mercka?s JUVISYNCa" (sitagliptin and .. Daily Therapy for Patients with Type 2 Diabetes W
[ Sat, Oct 08th 2011 ] - Market Wire
KCI Announces Proposed Offering of Senior Notes
[ Sat, Oct 08th 2011 ] - Market Wire
FDA Approves Mercka?s JUVISYNCa" (sitagliptin and .. e-Daily Therapy for Patients with Type 2 Diabetes
[ Sat, Oct 08th 2011 ] - Market Wire
IBM Launches University Competition to Combat Growth of Non-Communicable Diseases
[ Sat, Oct 08th 2011 ] - Market Wire
Amerigroup Enhances Maternal Outreach Efforts
[ Sat, Oct 08th 2011 ] - Market Wire
West Increases Quarterly Dividend to $0.18
[ Sat, Oct 08th 2011 ] - Market Wire
Watson Confirms District Court Order Concerning Generic Version of LOVENOX(R)
Fri, October 7, 2011
[ Fri, Oct 07th 2011 ] - Market Wire
U.S. Federal Trade Commission Clears Teva's Acquisition of Cephalon
[ Fri, Oct 07th 2011 ] - Market Wire
Celgene publica nueva informacin adicional sobre la conclusin del Artculo 20 para REVLIMID®
[ Fri, Oct 07th 2011 ] - Market Wire
Ligand to Present at the BioCentury NewsMakers Conference on October 21
[ Fri, Oct 07th 2011 ] - Market Wire
Poniard Pharmaceuticals Announces Effectiveness o .. n Statement for the Proposed Merger with ALLOZYNE
[ Fri, Oct 07th 2011 ] - Market Wire
NuVasive Completes Acquisition of Impulse Monitor .. and Conference Call of Third Quarter 2011 Results
[ Fri, Oct 07th 2011 ] - Market Wire
Law Offices of Howard G. Smith LLP Continues Inve .. ation of Pharmaceutical Product Development, Inc.
[ Fri, Oct 07th 2011 ] - Market Wire
Paladin Labs Completes Acquisition of Labopharm
[ Fri, Oct 07th 2011 ] - Market Wire
Advitech and Natunola Announce Completion of Merg .. Private Placement and Change of Name to Botaneco
[ Fri, Oct 07th 2011 ] - Market Wire
Akorn, Inc. Announces Third Quarter 2011 Earnings Release and Conference Call Information

Akorn, Inc. Announces Third Quarter 2011 Earnings Release and Conference Call Information


Published on 2011-10-07 10:02:20 - Market Wire
  Print publication without navigation


Akorn, Inc. Announces Third Quarter 2011 Earnings Release and Conference Call... -- LAKE FOREST, Ill., Oct. 7, 2011 /PRNewswire/ --

Akorn, Inc. Announces Third Quarter 2011 Earnings Release and Conference Call Information

[ ]

LAKE FOREST, Ill., Oct. 7, 2011 /PRNewswire/ -- Akorn, Inc. (NASDAQ: [ AKRX ]) will host a conference call on Tuesday, November 1, 2011, to discuss third quarter 2011 results followed by a Q&A session.  The company will release earnings the same day before the market opens.

Subject:

Akorn, Inc. Third Quarter 2011 Conference Call

Date/Time:

Tuesday, November 1, 2011, at 10:00 a.m. Eastern Time

Domestic Callers:

(888) 656-7422

International Callers:

(913) 312-0975

Confirmation Code:

4854021

URL For Webcast:

[ http://www.videonewswire.com/event.asp?id=82807 ]



A live broadcast of Akorn's conference call will also be available online at [ www.akorn.com ] under the Investor Relations tab on November 1, 2011, beginning at 10:00 a.m. (Eastern Time).  The online replay will follow immediately and will be available for 30 days.  

About Akorn, Inc.

Akorn, Inc. is a niche pharmaceutical company engaged in the development, manufacture and marketing of multisource and branded pharmaceuticals.  Akorn has manufacturing facilities located in Decatur, Illinois and Somerset, New Jersey where the Company manufactures ophthalmic and injectable pharmaceuticals.  Additional information is available on the Company's website at [ www.akorn.com ].

SOURCE Akorn, Inc.

[ Back to top ]

RELATED LINKS
[ http://www.akorn.com ]

Contributing Sources